Pharm
Benazapril
search
Benazapril
, Lotensin
See Also
ACE Inhibitor
Indications
See
ACE Inhibitor
Hypertension
Congestive Heart Failure
Mechanism
See
ACE Inhibitor
Carboxyl-containing
Angiotensin
-converting enzyme (ACE) inhibitor
Benazapril is a prodrug, converted to its active form benazeprilat in the liver
Dosing
Adults
Adequate 24 hour control may require divided dosing twice daily
Hypertension
Start 10 mg orally daily
Start at 5 mg orally daily in elderly,
Diuretic
use, GFR <30
Start at 5 mg in
Congestive Heart Failure
(CHF)
Target 20-40 mg/day
Maximum: 80 mg/day (40 mg/day in CHF)
Renal Dosing
GFR <30 ml/min: Start at 5 mg
Dosing
Children (age >=6 years old)
Contraindicated if GFR <30 ml/min or age <6 years old
Hypertension
Start 0.2 mg/kg/day up to 10 mg/day
Maximum: 0.6 mg/day up to 40 mg/day
Supplied
Available as unscored generic tablets: 5, 10, 20 and 40 mg
Metabolism
Primarily renal excretion (as benzeprilat)
Adverse Effects
See
ACE Inhibitor
Safety
See
ACE Inhibitor
Pregnancy Category X
Avoid in
Lactation
Resources
Benazapril (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a216253b-27cb-42ef-b5a8-67fb05aafb88
References
(2016) Presc Lett, Resource #321151, ACE Inhibitor
Antihypertensive
Dose Comparison
(2020) Med Lett Drugs Ther 62(1598): 73-80
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 68-9
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here